Quipt Home Medical Corp.

Equities

QIPT

CA74880P1045

Healthcare Facilities & Services

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
4.26 ^CAD	-7.79%		-22.40%	-36.89%

May. 17	Canaccord Genuity Adjusts Price Target on Quipt Home Medical to $8 From $9, Maintains Buy Rating	MT
May. 17	Raymond James Downgrades Quipt Home Medical to Underperform	MT

Patient Home Monitoring Corp. Announces Promotion of Greg Crawford to the Position of Chief Operating Officer

April 19, 2016 at 05:13 pm EDT

Patient Home Monitoring Corp. announced that it has promoted Greg Crawford to the position of Chief Operating Officer. Mr. Crawford joined the company through the company's purchase of Patient-Aids Inc. last year.

Latest news about Quipt Home Medical Corp.

Canaccord Genuity Adjusts Price Target on Quipt Home Medical to $8 From $9, Maintains Buy Rating	May. 17	MT
Raymond James Downgrades Quipt Home Medical to Underperform	May. 17	MT
Transcript : Quipt Home Medical Corp., Q2 2024 Earnings Call, May 16, 2024	May. 16
Quipt Home Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 15	CI
Quipt Home Medical Corp. Brief: Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue	May. 15	MT
Quipt Home Medical Corp. Brief: Revenue for Q2 2024 was US$64.0 million compared to $58.1 million for Q2 2023, representing a 10% increase	May. 15	MT
Quipt Home Medical Corp. announces an Equity Buyback for 3,626,845 shares, representing 8.52% of its issued share capital.	May. 02	CI
Quipt Home Medical Announces 10% Stock Buyback	May. 02	MT
Quipt Home Medical Corp. authorizes a Buyback Plan.	May. 01	CI
Quipt Home Medical Maintained at Buy at Stifel GMP After Fiscal Q1 Results; Price Target Cut to C$10.50	Feb. 16	MT
Transcript : Quipt Home Medical Corp., Q1 2024 Earnings Call, Feb 15, 2024	Feb. 15
Quipt Home Medical Corp. Brief: Revenue for Q1 2024 was US$65.4 million compared to $40.8 million for Q1 2023; Net income (loss) for Q1 2024 was $(0.6) million, or ($0.01) per diluted share	Feb. 14	MT
Quipt Home Medical Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 14	CI
North American Morning Briefing :Stock Futures -2-	Feb. 14	DJ
Quipt Home Medical Corp. Brief: Shelf Prospectus and Registration Statement, when made final and effective, will enable Co to offer Up to C$300,000,000 of common shares, preferred shares, debt securities, warrants	Dec. 27	MT
Quipt Home Medical Corp. Brief: Announced Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus	Dec. 27	MT
Transcript : Quipt Home Medical Corp., Q4 2023 Earnings Call, Dec 19, 2023	Dec. 19
Quipt Home Medical Corp. Up 3% In US After Hours Despite Q4 Net Loss; But Revs and Recurring Revs "Very Strong"	Dec. 18	MT
Quipt Home Medical Corp. Brief: Adds Company "Maintains a conservative balance sheet" with net debt to Adjusted EBITDA leverage of 1.4x	Dec. 18	MT
Quipt Home Medical Corp. Brief: Says Recurring Revenue for Q4 2023 was "Very Strong" and Exceeded 83% of total revenue, driven by growth in the Company's resupply platform	Dec. 18	MT
Quipt Home Medical Corp. Brief: Revenue for Q4 2023 was US$62.5 million compared to $40.1 million for Q4 2022, representing a 56% increase	Dec. 18	MT
Quipt Home Medical Corp. Brief: Net Loss for Q4 2023 was US($1.3) million, or ($0.03) per diluted share, as compared to $1.8 million, or $0.05 per diluted share for Q4 2022	Dec. 18	MT
Quipt Home Medical Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2023	Dec. 18	CI
North American Morning Briefing : Stock Futures -2-	Dec. 18	DJ
North American Morning Briefing : Stock Futures Edge Up to Start the Week	Dec. 18	DJ

Chart Quipt Home Medical Corp.

Duration

Period

More charts

Company Profile

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.

Sector

Healthcare Facilities & Services

Calendar

2024-05-20 - Benchmark Healthcare House Virtual Conference

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Quipt Home Medical Corp.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.26 CAD

Average target price

12.67 CAD

Spread / Average Target

+197.34%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
QUIPT HOME MEDICAL CORP.	-36.89%	144M
HCA HEALTHCARE, INC.	+19.28%	84.52B
CVS HEALTH CORPORATION	-26.95%	72.21B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+4.65%	27.74B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-7.35%	17.97B
FRESENIUS SE & CO. KGAA	-0.46%	17.46B
QUEST DIAGNOSTICS INCORPORATED	+4.69%	15.82B
REDE D'OR SÃO LUIZ S.A.	+8.14%	13.55B
FRESENIUS MEDICAL CARE AG	+6.59%	13.31B
TENET HEALTHCARE CORPORATION	+70.00%	12.5B

Other Healthcare Facilities & Services